Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model

Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model

The highly efficacious live-attenuated 17D yellow fever (YF) vaccine is occasionally associated with rare life-threatening adverse events. Modified vaccinia virus Ankara (MVA), a non-replicating poxvirus, has been used as a vaccine platform to safely deliver various antigens. A MVA-based YF vaccine...

Full description

Bibliographic Details
Main Authors: Justin G. Julander, Marco Testori, Cédric Cheminay, Ariane Volkmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Immunology
Subjects:
yellow fever
17D
passive immunization
hamster
modified vaccinia virus Ankara
neutralizing antibodies
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01756/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2018.01756/full

Similar Items